Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
1365655-91-9
756525-91-4
882847-13-4
1347750-75-7
1347750-78-0
2062663-65-2 | Aminooxy-peg3-nh-boc | AA019E7N | MFCD30536148
60696-83-5 | 2-(2-Methoxyethoxy)ethyl methanesulfonate | AA019EC3 | MFCD00955893
2183473-45-0 | BDP FL hydrazide | AA019EGG | MFCD31580094
953029-91-9 | N-Isopropyl-1H-indole-5-carboxamide | AA019EJX | MFCD13177550
1140506-56-4 | 2-((4-Fluorophenyl)sulfonyl)nicotinaldehyde | AA019EMY | MFCD29917040
1033743-25-7 | 2-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol | AA019EQ4 | MFCD28966046
1046817-01-9 | 1-(5-Ethylpyrimidin-2-yl)piperidin-4-yl methanesulfonate | AA019ET3 | MFCD29084721
83190-01-6 | 4-(Difluoromethoxy)-3-fluoroaniline | AA019EWL | MFCD11621754
449211-79-4 | 2-(4-Chloromethyl-Phenyl)-2H-[1,2,3]Triazole | AA019EZH | MFCD30185866
91-30-5 | 5-Amino-2-(phenylamino)benzenesulfonic acid | AA019FTX | MFCD00035932